Fenwick & West advised Sema4 on the deal.Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an OPKO…
Sema4’s Acquisition of GeneDx


Fenwick & West advised Sema4 on the deal.Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an OPKO…
…